References
- Beck L R., et al. Clinical evaluation of injectable biodegradable contraceptive system. Am.J. Obstet. Gynecol 1981; 140: 799–806
- Beck L R., et al. Poly (DL-lactide-co - glycolide) / Norethisterone microcapsules : An injectable biodegradable contraceptive. Biology of Reproduction 1983a; 28: 186–195
- Beck L R., . Poly(lactic acid) and poly (lactic acid-co -glycolic acid) contraception, D. R. Mishell, Jr, et al. Roven, press, New york 1983b; 175–199
- Benoit J. P., et al. A phsicochemical study of the morphology of progesterone-loaded poly (DL-lactide) microspheres. Int. J. Pharm 1986; 29: 95–102
- Bialy G, et al. Long-acting contraceptive agents: structure activity relationships in a series of norethisterone and levonorgestrel esters. Sterolds 1983; 41: 419–439
- Chang T. M.S. Biodegradable microcapsules containing enzymes, hormones, vaccines and other biologicals. J. of Bioengineering 1976; 1: 25–32
- Grubb G S, et al. A comparative evaluation of the safety and contraceptive effectiveness of 65mg and 100mg of 90-days norethistrerone (NET) injectable microspheres: a multicenter study. Fertility and Sterility 1989; 51: 803–810
- Higuch W I. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drug disperse in solid matrices. J. Pharm. Sci 1963; 52: 1145–1149
- Naoki Wakiyama, et al. preparetion and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine. Chm. Pharm. Bull 1982; 30: 3719–3727
- Lodge B. A, et al. Thin-layer chromatography/mass spectrometry in the study of the impurities of norethindrone and norethindrone acetate. Canadian J. of Pharm. Sci 1974; 9: 41–43
- Sanders L. M, et al. Microencapsulation of LH-RH analogue using biodegradable polymers. J. of controlled release 1985; 2: 187–195
- Spenlehauer G, et al. Formation and characterization of cisplatin loaded poly(DL-lactide) microspheres for chemoembolization. J. Pharm. Sci 1986; 75: 750–755